MedTrace Logo

An Observational Study of Menopausal Symptom in Patients With Gynecological Malignancy After Oophorectomy

NCT06151028 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 490

Last updated 2024-03-07

No results posted yet for this study

Summary

Through long-term dynamic monitoring of gynecologic malignant tumor patients undergoing early menopause after ovaries resection in our center, we explored the changes in menopausal symptoms and bone health status of this population, and studied the effects of platinum combined chemotherapy drugs on menopausal symptoms and bone loss in gynecologic malignant tumor patients. To find the optimal time point and effective regimen for MHT in gynecologic malignancies undergoing surgical menopause, and to provide guidance for osteoporosis screening and prevention strategies in women with gynecologic cancer.

Conditions

  • Gynecological Malignancies
  • Menopausal Symptoms
  • Bone Loss

Interventions

OTHER

No intervention

This is an observational study and did not involve interventions.

Sponsors & Collaborators

  • Anhui Provincial Hospital

    lead OTHER_GOV

Principal Investigators

  • Ying Zhou, MD · The First Affiliated Hospital of USTC (Anhui Provincial Hospital)

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2028-12-31
Completion
2033-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06151028 on ClinicalTrials.gov